From: Inhibitors of apoptosis proteins in human cervical cancer
Factor | Hazard ratio (95% CI) | p |
---|---|---|
(A) Univariate analysis of disease-free survival | ||
FIGO stage | 2.41 (1.10â5.00) | 0.018 |
Age | 1.00 (0.97â1.00) | 0.075 |
Menopause | 0.77 (0.46â1.31) | 0.063 |
Histology | 2.58 (1.24â5.41) | 0.011 |
Survivin | 0.99 (0.99â1.00) | 0.295 |
Survivin2B | 1.00 (0.99â1.01) | 0.592 |
SurvivinÎEx3 | 1.00 (0.99â1.02) | 0.187 |
XIAP | 0.69 (0.59â0.94) | 0.048 |
c-IAP1 | 0.99 (0.98â1.01) | 0.334 |
c-IAP2 | 0.98 (0.96â1.00) | 0.115 |
(B) Multivariate Cox model of disease-free survival | ||
FIGO stage | 3.13 (1.11â8.81) | 0.031 |
Age | 1.06 (0.98â1.13) | 0.108 |
Menopause | 0.29 (0.07â1.20) | 0.089 |
Histology | 1.77 (0.71â4.41) | 0.071 |
Survivin | 0.97 (0.99â1.00) | 0.374 |
Survivin2B | 1.00 (0.07â1.03) | 0.743 |
SurvivinÎEx3 | 0.99 (0.07â1.02) | 0.882 |
XIAP | 0.79 (0.69â0.96) | 0.516 |
c-IAP1 | 0.99 (0.97â1.01) | 0.548 |
c-IAP2 | 0.99 (0.98â1.00) | 0.486 |